Deutsche Bank
FOLD

Deutsche Bank’s Amicus Therapeutics FOLD Stock Holding History

Deutsche Bank’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$7K – 5234
2015
Q2 		$7K Buy
+500
New +$6.01K ﹤0.01% 5106

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Deutsche Bank's FOLD Position: Q2 2026 in Review

Deutsche Bank sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 282,792 shares — an estimated $4.09M sold.

Deutsche Bank first reported a position in FOLD in Q2 2013 and held it in 52 quarters. The position peaked at $127M in Q4 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Deutsche Bank reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Deutsche Bank sold 282,792 Amicus Therapeutics shares in Q2 2026, an estimated $4.09M.
  • Deutsche Bank first reported a position in Amicus Therapeutics in Q2 2013 and held it in 52 quarters.
  • Deutsche Bank's Amicus Therapeutics position peaked at $127M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.